Skip to content

Future of T1D Research

JDRF is creating a future without type 1 diabetes (T1D) by funding and advocating for breakthrough scientific research. One of our strategies is to help promising scientists establish careers in the field of T1D research. The investigators featured here form the newest group to receive early-career funding from JDRF. Meet the future of T1D research.

Career Development Awards

These awards are designed to attract exceptionally promising investigators early in their faculty careers. In the five-year term of the award, grantees will have the opportunity to position themselves at the leading edge of T1D research, on a subject directly related to JDRF mission goals and research priorities.

Early Career Patient-Oriented Diabetes Research Awards

These awards are intended for clinical researchers at a relatively early stage of their independent career. Recipients must have an M.D. or M.D.-Ph.D., hold an appointment or joint appointment in a subspecialty of clinical medicine in a clinical department and conduct clinical research.

Advanced Postdoctoral Fellowships

These awards are designed to attract qualified and promising health scientists to receive full-time research training, assisting these promising individuals in the transition from a fellowship to an independent position. This three-year award term has an optional one-year transition award, to serve as a bridge between the fellowship and an independent faculty appointment.

Eleni Beli, Ph.D.

Novel insights on the link between diabetic retinopathy and the splenic clock

Indiana University

Erine Budi, Ph.D.

Integration of increased TGF-beta signaling in the cellular response to insulin or high glucose

University of California, San Francisco

Heather Denroche, Ph.D.

Targeting islet amyloid for diabetes prevention and improved beta cell replacement therapy

The University of British Columbia

Chiara Fabris, Ph.D.

CGM-based insulin sensitivity estimation to improve insulin dosing in T1D

The University of Virginia

Nina Funa, Ph.D.

Identification of signaling pathways controlling expansion of human pancreatic progenitor cells

The Danish Stem Cell Center, The University of Copenhagen

Link to blog post

Manoj Gupta, Ph.D.

Modeling T1D and its associated complications using human induced pluripotent stem cells

Joslin Diabetes Center

Zeno Lavagnino, Ph.D.

Quantitative multiscale imaging to investigate the regulation of glucagon secretion in pancreatic islet

Washington University

Anna Long, Ph.D.

Adult onset T1D: Slow progressors or late starters?

University of Bristol

Adriana Migliorini, Ph.D.

Macrophages-endocrine cross talk during human pancreas development

McEwen Centre for Regenerative Medicine, Toronto General Research Institute, University Health Network

Candace Reno, Ph.D.

Preventing severe hypoglycemia-induced cardiac arrhythmias

University of Utah

Xuewei Wang, Ph.D.

Nitric oxide-releasing cannula integrated with glucose electrode for long-term single-port glycemic control

The University of Michigan

Link to blog post

Postdoctoral Fellowships

Postdoctoral fellowships are designed to attract qualified, promising scientists in the T1D research field. These recipients are to work with a sponsor who can provide a training environment conducive to beginning a professional career in T1D-related research.

Satoru Akazawa, M.D., Ph.D.

Defining a new role for granzyme A in maintaining immune tolerance

St. Vincent's Institute of Medical Research

Jenny Aurielle Babon, Ph.D.

Autoreactive CD8 T cell infiltrates from the islets of human subjects with T1D

University of Massachusetts Medical School

Romina Bevacqua, Ph.D.

Innovating genetic studies to promote human islet regeneration

Stanford University

Chandrabali Bhattacharya, Ph.D.

Novel glucose-responsive tripeptides for smart insulin

Massachusetts Institute of Technology

Robert Bone, Ph.D.

ER calcium dyshomeostasis in the pathogenesis of T1D

Indiana University

Mijke Buitinga, Ph.D.

Post-translational modification of beta-cell proteins: Towards a better understanding and detection of T1D

KU Leuven, Belgium

Diao Chen, Ph.D.

Development of glucose-responsive insulin derivatives

University of Utah

Yi-Chun Chen, Ph.D.

Alternatively processed forms of islet amyloid polypeptide as predictive biomarkers for T1D

The University of British Columbia

Yen-Shan Chen, Ph.D.

Design of a glucose-responsive insulin based on a conformational switch

Case Western Reserve University

Link to blog post

Devy Deliyanti, Ph.D.

Boosting the immune system to treat diabetic retinopathy

Monash University

Joseph Feduska, Ph.D.

Oxidative post-translational modification of T1D autoantigens

University of Alabama at Birmingham

Laura Jacobsen, M.D.

Characterization of T cell autoreactivity in T1D

University of Florida

Piotr Kowalski, Ph.D.

Engineering mRNA nanocarriers to rescue pancreatic beta cells in T1D

Massachusetts Institute of Technology

Link to blog post

Purushothaman Kuppan, Ph.D.

Novel functionalized retrievable scaffolds for islet transplantation

The University of Alberta

Yunxian Liu, Ph.D.

Systematic identification and validation of causal variants and genes targets associated with T1D

The University of Virginia

Wentong Long, Ph.D.

Bioengineering adipocytes for the regulated release of bioactive insulin

The University of Alberta

Silvia Minardi, M.Sc., Ph.D.

Multifunctional bio-inspired nanodelivery systems for T1D

Northwestern University

Tobias Neef, Ph.D.

Biodegradable PLG nanoparticles for tolerance induction in T1D

Northwestern University

Kim-Vy Nguyen-Ngoc, Ph.D.

Establishing vascularized human pancreatic islets from hESCs

University of California, San Diego

Vishwendra Patel, Ph.D.

The role of perifornical hypothalamic orexin-glucose inhibited neurons in hypoglycemia awareness

Rutgers, The State University of New Jersey

Kacey Prentice, Ph.D.

Targeting lipid chaperone adipocyte protein 2 (aP2) for the prevention of T1D

Harvard University

Ronan Russell, Ph.D.

Investigating the role of MAFA and MAFB in human beta cell specification and maturation using hESCs as a model

University of California, San Francisco

Shugo Sasaki, M.D., Ph.D.

Protecting insulin-producing beta cell transplants from death and dysfunction, funded by MilliporeSigma

The University of British Columbia

Elad Sintov, Ph.D.

Genetic screening for immune-tolerance inducers in stem cell-derived beta cells for cell replacement therapy of T1D, funded by MilliporeSigma

Harvard University

Link to blog post

Alexandra Smink, Ph.D.

Towards efficacious oxygen exchanging vasculature in a retrievable PDCCL scaffolds for islet transplantation

University Medical Center Groningen

Subhash Tripathi, Ph.D.

Cell specific epigenetic landscape in children with T1D

University of Turku, Finland

Verena van der Heide, M.D.

Mapping the histopathological landscape of the pre-/diabetic human pancreas

Icahn School of Medicine at Mount Sinai

Saurabh Vig, Ph.D.

Role of surface-expressed glucose-regulated protein 78 in beta cells and their cross-talk with the immune system

KU Leuven

Jessica Weaver, Ph.D.

Localized immunomodulation to induce tolerance in an extrahepatic encapsulated islet graft

Georgia Institute of Technology

Link to blog post

Xiaochun Xiong, Ph.D.

Development of an ultrafast-acting insulin

University of Utah

Ebrahim Zadeh, Ph.D.

Targeted delivery of adiponectin receptor agonists for promoting beta cell regeneration and survival

UT Southwestern Medical Center

Psychology Fellowships

These awards are designed to increase the capacity in diabetes clinical psychology and diabetes psychology research. It is a combination of clinical diabetes care and diabetes research, and each recipient should have a career interest in diabetes-specialized psychology.

Lindsay Anderson, M.A.

Ann and Robert H. Lurie Children’s Hospital of Chicago

Samantha Barry, Ph.D.

University of Massachusetts Medical School

Sarah Westen, Ph.D.

Sleep, adherence and glycemic control in adolescents with T1D

University of Florida

JDRF-ISPAD Fellowships

These awards are designed for International Society for Pediatric and Adolescent Diabetes (ISPAD) members below age 40 (or 45 for the Allan Drash Clinical Fellowship), who wish to pursue a career in diabetes related research. It is designed to cover expenses to an ISPAD member’s Centre of Excellence.

Naina Bhat, M.D.

Allan Drash Clinical Fellowship

St John’s Medical College and Hospital, Bangalore, India

Link to blog post

Petter Bjornstadt, M.D.

Diabetic Kidney Alarm study: Tubulopathy in new onset diabetic ketoacidosis

University of Colorado School of Medicine, Colorado, US

Link to blog post

Mohammad Hosny, M.D.

Allan Drash Clinical Fellowship

Mansoura University Children’s Hospital, Mansoura, Egypt

Link to blog post

Wafaa Laymoun, M.D., Ph.D.

Allan Drash Clinical Fellowship

Mansoura University Children’s Hospital, Mansoura, Egypt

Link to blog post

Beata Malachowska, M.D., Ph.D.

Role of lysophosphatidic acid, and elevated serum biomarker, in pathogenesis of HNF1B mediated MODY

Medical University of Lodz, Lodz, Poland

Link to blog post

Joshua Ngwang Menang, R.N.

Allan Drash Clinical Fellowship

Cameroon Laboratory & Medicine Foundation Health Center, Tiko, Cameroon

Link to blog post

Feny Patel, M.D.

Allan Drash Clinical Fellowship

Clinic Ahmedabad, Gujarat, India

Link to blog post

Marie Beatrice Saade, M.D.

Efficacy of two carbohydrate intake strategies with similar carbohydrate content but different timing to reduce exercise-induced hypoglycemia in children with type 1 diabetes

Institut de Recherches Cliniques de Montréal, Montreal, Canada

Link to blog post

Arun Kumar Singh, M.D.

Allan Drash Clinical Fellowship

B. P. Koirala Institute of Health Sciences, Dharan, Nepal

Link to blog post

Gianluca Tornese, M.D., Ph.D.

Role of "taste" in metabolic regulation in T1D and mapping of mechanistically involved genes and pathways

Institute for Maternal and Child Health “Burlo Garofolo,” Trieste, Italy

Link to blog post

Get Involved

By donating your time or dollars, you are funding promising new scientists who share our mission of ending T1D.